Asolution Pharmaceutical Pvt Ltd Rating Rationales / Reports

Title MID: 90223 21-May-2025 Issuer did not cooperate; Based on best available information; View Report MID: 78028 12-May-2025 Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory; View Report MID: 78028 10-May-2024 Issuer did not cooperate; Based on best available information; Outstanding Ratings Reaffirmed; View Report MID: 70130 23-Feb-2024 Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory; View Report MID: 70130 22-Feb-2023 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR C; View Report MID: 58177 03-Mar-2022 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR B -; View Report MID: 46553 15-Jan-2021 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR B; View Report MID: 32043 09-Oct-2019 Outstanding Ratings Reaffirmed; View Report MID: 23930 13-Jun-2018 Outstanding Ratings Reaffirmed; View Report MID: 15340 16-Dec-2016 Long Term Rating BWR B +/Stable Assigned; Short Term Rating BWR A4 Assigned; View Report